Clearpoint Neuro (NASDAQ: CLPT) — Perfil da empresa, notícias e dados financeiros
Clearpoint Neuro specializes in technology for neurosurgery, enhancing precision through minimally invasive surgical solutions.
Clearpoint Neuro
Clearpoint Neuro (NASDAQ:CLPT) specializes in providing innovative technology and services for the treatment of various neurological disorders. This company focuses on the development and commercialization of navigation and delivery technologies to allow for minimally invasive surgeries within the brain. With projects ranging from surgical navigation systems to therapy delivery platforms, Clearpoint Neuro aims to improve the precision and safety of neurosurgical procedures. Their objectives include expanding their technology's use to support biologics and drug delivery, as well as fostering collaborations with leading institutions and companies to propel advancements in neurosurgery. Clearpoint Neuro is dedicated to transforming how neurological disorders are treated, enhancing patient outcomes and advancing the field of neurosurgery.
Resumo
Operações
Produtos e/ou serviços de Clearpoint Neuro
- MRI-guided neurosurgical navigation systems enable precise access to the brain and spine for therapy delivery and biopsies.
- SmartFlow cannula designed for delivering therapeutics into the brain with accuracy.
- Clinical research services supporting biotech and pharmaceutical companies in developing CNS therapeutics.
- Neuro Navigation System integration compatible with various MRI systems for enhanced imaging and surgical planning.
- Software and hardware upgrades for existing navigation systems, improving functionality and extending system life.
- Training and education programs for surgeons and medical staff, ensuring effective use of their technology.
equipe executiva do Clearpoint Neuro
- Joseph Michael BurnettPresident, CEO & Director
- Danilo D'AlessandroChief Financial Officer
- Jeremy L. StigallChief Business Officer
- Mazin SabraChief Operating Officer
- Robert C. KornSenior Vice President of Sales & Business Development
- Paul S. LarsonChief Medical Officer
- Mary McNamara-CullinaneSenior Vice President of Regulatory Affairs
- Megan FaulkenberrySenior Vice President of Quality
Principais indicadores financeiros
Resultados divulgados pela Clearpoint Neuro, em USD.
- Cap. de mercado
- 322,1 mi
- Receita (TTM)
- 42,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.3
- Dividend yield
- —
- Margem de lucro
- -81.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 37 mi | -24,2 mi | -25,5 mi | |
| 31,4 mi | -19,7 mi | -18,9 mi | |
| 24 mi | -22,4 mi | -22,1 mi | |
| 20,6 mi | -16,3 mi | -16,4 mi |